Cardinal Health today announced plans to expand its presence in specialty pharmaceutical services with a definitive agreement to purchase Healthcare Solutions Holding, LLC in an upfront $517 million all-cash transaction.
The agreement also includes the opportunity for earn-out payments of up to $150 million over the next three years.
Healthcare Solutions Holding is the parent company of a number of subsidiaries including P4 Pathways and P4 Healthcare. These businesses serve key participants across the chain of specialty care including physicians, pharmaceutical companies and payors by providing essential tools, services and data to help improve the quality of patient outcomes and increase efficiency in the delivery of health care services. The acquisition will expand Cardinal Health’s current capabilities and reach in specialty pharmaceuticals, a segment of the market which IMS Health forecasts will grow at twice the rate of traditional pharmaceuticals for the next five years and exceed $100 billion in sales by 2013.
[BioSpace]
The United States Department of Energy offered a $1.37 billion loan guarantee on Monday to a California company planning to build a large-scale solar power plant in the Southern California desert. ... Read More
The Springfield Area Chamber of Commerce says Kraft Foods Inc. plans to invest $9 million in two new manufacturing lines in the Springfield area. The company says the investment will bring ... Read More
Sales of vehicles powered by fuel cells running on hydrogen will surge over the next 10 years, according to a report released Tuesday by Pike Research. By 2014 fuel cell vehicles ... Read More
Big Blue announced Monday that it will team up with partners and customers to venture into the next phase of its Smarter Planet initiative: Smarter Buildings. The goal is to help ... Read More
Boeing Co. said on Friday that it sent layoff notices to more than 1,000 people, including nearly 100 in the St. Louis. Most of the layoffs were technology workers in Washington ... Read More
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved Mirapex ER® extended-release tablets, a new once-daily treatment option for the signs and symptoms of early ... Read More
Swiss drugmaker Novartis AG said Monday that its meningitis vaccine Menveo has been approved for use in teenagers and adults by the U.S. Food and Drug Administration. Menveo is a vaccine ... Read More
Iron Mountain said Monday that it is picking up Mimosa Systems in a deal worth $112 million. Mimosa specializes in enterprise content archiving systems. Iron Mountain focuses on data archiving, e-discovery ... Read More
Billionaire investor Carl Icahn is backing a startup company that would build trains to run on President Barack Obama’s high-speed rail network, challenging international manufacturers that dominate the market, the company ... Read More
Peabody Energy Corp. said today that it has signed an agreement with Cambridge, Mass.-based GreatPoint Energy to develop plants that would convert coal to synthetic gas and hydrogen. The number of ... Read More